MUMBAI, India, March 28 -- Intellectual Property India has published a patent application (202527015963 A) filed by Sun Pharma Advanced Research Company Limited, Maharashtra, on Feb. 24, for 'methods of treating chronic myeloid leukemia using the tyrosine kinase inhibitor vodobatinib.'
Inventor(s) include Chimote, Geetanjali Chandrasekhar; Talluri, Ravi Sankar Prasad; and Ramanathan, Vikram.
The application for the patent was published on March 28, under issue no. 13/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to methods of treating leukemia using Tyrosine Kinase inhibitors. The invention particularly relates to methods of treating CML and ALL using a compound of Formula I o...